ZB
Zions Bancorporation Portfolio holdings
AUM
$1.59B
1-Year Return
19.92%
This Quarter Return
+7.24%
1 Year Return
+19.92%
3 Year Return
+22.91%
5 Year Return
+70.05%
10 Year Return
+136.16%
AUM
$1.13B
AUM Growth
+$153M
(+16%)
Cap. Flow
+$87.4M
Cap. Flow
% of AUM
7.73%
Top 10 Holdings %
Top 10 Hldgs %
62.63%
Holding
1,090
New
38
Increased
498
Reduced
241
Closed
70
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$32.2M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$16.6M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$12.4M |
| 4 |
VanEck High Yield Muni ETF
HYD
|
+$6.38M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$3.55M |
Top Sells
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$9.61M |
| 2 |
Huntsman Corp
HUN
|
+$1.81M |
| 3 |
Qualcomm
QCOM
|
+$1.75M |
| 4 |
PepsiCo
PEP
|
+$1.47M |
| 5 |
IBM
IBM
|
+$1.26M |
Sector Composition
| 1 | Technology | 8.29% |
| 2 | Healthcare | 5.33% |
| 3 | Financials | 3.52% |
| 4 | Consumer Discretionary | 3.51% |
| 5 | Communication Services | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$659B
| $4.33M | 0.38% |
19,997
+329
| +2% | +$71.3K |
|
27
Gilead Sciences
GILD
$142B
| $4.15M | 0.37% |
57,112
+3,675
| +7% | +$267K |
|
28
British American Tobacco
BTI
$123B
| $4.14M | 0.37% |
110,772
+10,938
| +11% | +$409K |
|
29
Vanguard FTSE Developed Markets ETF
VEA
$174B
| $4.1M | 0.36% |
80,384
+42,905
| +114% | +$2.19M |
|
30
Verizon
VZ
$185B
| $4.08M | 0.36% |
78,571
+698
| +0.9% | +$36.3K |
|
31
iShares Core S&P 500 ETF
IVV
$675B
| $3.93M | 0.35% |
8,229
+571
| +7% | +$272K |
|
32
Southern Company
SO
$102B
| $3.87M | 0.34% |
56,383
+3,537
| +7% | +$243K |
|
33
Philip Morris
PM
$259B
| $3.84M | 0.34% |
40,417
+1,795
| +5% | +$171K |
|
34
BCE
BCE
$22.5B
| $3.81M | 0.34% |
73,221
+4,658
| +7% | +$242K |
|
35
Crown Castle
CCI
$41.5B
| $3.77M | 0.33% |
18,042
+3,775
| +26% | +$788K |
|
36
Salesforce
CRM
$231B
| $3.71M | 0.33% |
14,612
+1,551
| +12% | +$394K |
|
37
Unilever
UL
$154B
| $3.67M | 0.32% |
68,306
+3,100
| +5% | +$167K |
|
38
Pfizer
PFE
$136B
| $3.67M | 0.32% |
62,101
-14,295
| -19% | -$844K |
|
39
Adobe
ADBE
$148B
| $3.61M | 0.32% |
6,363
+230
| +4% | +$130K |
|
40
Enbridge
ENB
$107B
| $3.59M | 0.32% |
91,867
+5,663
| +7% | +$221K |
|
41
Duke Energy
DUK
$94.8B
| $3.42M | 0.3% |
32,644
+1,969
| +6% | +$207K |
|
42
Thermo Fisher Scientific
TMO
$181B
| $3.26M | 0.29% |
4,879
+408
| +9% | +$272K |
|
43
National Grid
NGG
$71B
| $3.14M | 0.28% |
47,607
+2,235
| +5% | +$148K |
|
|
44
PepsiCo
PEP
$197B
| $3.14M | 0.28% |
18,062
-8,448
| -32% | -$1.47M |
|
45
AT&T
T
$211B
| $3.06M | 0.27% |
164,484
+754
| +0.5% | +$14K |
|
46
Truist Financial
TFC
$58.3B
| $3.04M | 0.27% |
51,903
+3,162
| +6% | +$185K |
|
47
American Electric Power
AEP
$58.5B
| $2.98M | 0.26% |
33,491
+2,137
| +7% | +$190K |
|
48
Zoetis
ZTS
$65.7B
| $2.97M | 0.26% |
12,180
+1,097
| +10% | +$268K |
|
49
iShares Russell 2000 Growth ETF
IWO
$12.6B
| $2.83M | 0.25% |
9,655
+1,864
| +24% | +$546K |
|
50
JPMorgan Chase
JPM
$844B
| $2.76M | 0.24% |
17,411
+558
| +3% | +$88.4K |
|